(Total Views: 695)
Posted On: 01/22/2020 5:03:27 AM
Post# of 149059
PR just in..
" Impressive results continue from CytoDyn's Clinical trial evaluating two patients with Leronlimab, one in mTNBC and one in MBC "
Patient # 1 CTC is zero in 15 weeks.
Patient # 2 ( M-i-L)..50% shrinking of primary tumor and no signs of metastasis in the brain after treatment with Leronlimab as a...MONOTHERAPY !!!!!!
PLEASE notice MONOTHERAPY.....
" Impressive results continue from CytoDyn's Clinical trial evaluating two patients with Leronlimab, one in mTNBC and one in MBC "
Patient # 1 CTC is zero in 15 weeks.
Patient # 2 ( M-i-L)..50% shrinking of primary tumor and no signs of metastasis in the brain after treatment with Leronlimab as a...MONOTHERAPY !!!!!!
PLEASE notice MONOTHERAPY.....
(6)
(0)Scroll down for more posts ▼
